Header Logo

Lauren Dockery

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
5
2026
349
1.530
 Why?
Ovarian Neoplasms
7
2026
610
1.380
 Why?
Uterine Cervical Neoplasms
2
2022
305
1.030
 Why?
Endometrial Neoplasms
2
2025
189
0.830
 Why?
Vulvar Neoplasms
1
2021
25
0.660
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
38
0.660
 Why?
Carcinoma in Situ
1
2021
46
0.650
 Why?
Disease Management
1
2021
91
0.630
 Why?
Platinum Compounds
1
2019
14
0.610
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
434
0.550
 Why?
Patient Navigation
1
2018
8
0.550
 Why?
United States Indian Health Service
1
2018
18
0.540
 Why?
Phthalazines
1
2017
25
0.520
 Why?
Piperazines
1
2017
50
0.510
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.500
 Why?
Antineoplastic Agents
1
2019
685
0.410
 Why?
Indians, North American
1
2018
548
0.390
 Why?
Female
11
2026
15825
0.330
 Why?
Bevacizumab
2
2022
106
0.320
 Why?
Aged
6
2026
5648
0.290
 Why?
Molecular Targeted Therapy
2
2020
137
0.280
 Why?
Humans
11
2026
29211
0.240
 Why?
Retrospective Studies
4
2024
2662
0.240
 Why?
Aged, 80 and over
3
2025
2070
0.240
 Why?
Granulosa Cell Tumor
1
2026
5
0.240
 Why?
CD47 Antigen
1
2025
4
0.220
 Why?
CD40 Antigens
1
2025
14
0.220
 Why?
Machine Learning
1
2025
98
0.210
 Why?
Middle Aged
5
2026
7495
0.200
 Why?
Neoadjuvant Therapy
1
2024
80
0.200
 Why?
Prealbumin
1
2022
4
0.190
 Why?
Endometrium
1
2022
39
0.180
 Why?
Cervix Uteri
1
2022
65
0.180
 Why?
Adult
4
2026
8130
0.170
 Why?
Indoles
1
2022
112
0.170
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.170
 Why?
Vulva
1
2021
5
0.170
 Why?
Indazoles
1
2020
18
0.160
 Why?
Papillomaviridae
1
2021
90
0.160
 Why?
Fallopian Tube Neoplasms
1
2020
53
0.160
 Why?
Piperidines
1
2020
48
0.150
 Why?
Peritoneal Neoplasms
1
2020
80
0.150
 Why?
Disease-Free Survival
1
2019
236
0.150
 Why?
Papillomavirus Infections
1
2021
159
0.140
 Why?
Patient Compliance
1
2018
77
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
26
0.130
 Why?
Disease Progression
1
2019
483
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
32
0.130
 Why?
Treatment Outcome
2
2020
2442
0.120
 Why?
Randomized Controlled Trials as Topic
1
2017
415
0.110
 Why?
Age Factors
1
2017
740
0.110
 Why?
Risk Factors
1
2021
2144
0.110
 Why?
Prospective Studies
1
2017
1288
0.100
 Why?
United States
1
2018
2270
0.090
 Why?
Young Adult
1
2018
2877
0.080
 Why?
Adolescent
1
2018
3255
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
5
0.060
 Why?
Recombinant Fusion Proteins
1
2025
234
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
172
0.050
 Why?
Interleukin-8
1
2022
45
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Predictive Value of Tests
1
2024
484
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
118
0.050
 Why?
Vitamin D
1
2022
54
0.050
 Why?
Interleukin-6
1
2022
198
0.040
 Why?
Pilot Projects
1
2022
467
0.040
 Why?
Biomarkers
1
2022
790
0.040
 Why?
Prognosis
1
2020
817
0.030
 Why?
Postoperative Complications
1
2022
643
0.030
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (24)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_